Difference between revisions of "Adenocarcinoma in situ"

Revision as of 14:53, 5 June 2016

Adenocarcinoma in situ, abbreviated AIS, refers to a non-invasive gland-forming neoplasm.

It often refers to:

It may refer to:

Adenocarcinoma in situ of the urinary bladder - see adenocarcinoma of the urinary bladder.
Adenocarcinoma in situ of the lung.
- Not diagnosed on small biopsies.^[1]

↑ Travis WD, Brambilla E, Noguchi M, et al. (February 2011). "International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma". J Thorac Oncol 6 (2): 244–85. doi:10.1097/JTO.0b013e318206a221. PMID 21252716.

Revision as of 15:21, 12 January 2016 (view source) Michael (talk \| contribs) (→‎See also) ← Older edit		Revision as of 14:53, 5 June 2016 (view source) Michael (talk \| contribs) Newer edit →
Line 1:		Line 1:
			[[Image:Endocervical adenocarcinoma in situ --- high mag.jpg\|thumb\|right\|[[Endocervical AIS]]. [[H&E stain]]. (WC/Nephron)]]
	'''Adenocarcinoma in situ''', abbreviated '''AIS''', refers to a non-invasive gland-forming neoplasm.		'''Adenocarcinoma in situ''', abbreviated '''AIS''', refers to a non-invasive gland-forming neoplasm.